Professional Documents
Culture Documents
Approach Tachycardia is defined as a heart rate above 100 beats per minute.
Management of tachydysrhythmias is governed by the presence of clinical symptoms and
signs caused by the rapid heart rate (show algorithm 7).
First determine if the patient is unstable (eg, has ongoing ischemic chest pain, mental
status changes, hypotension, or signs of acute pulmonary edema). If the instability appears
related to the tachycardia, treat immediately with synchronized cardioversion, unless the
rhythm is sinus tachycardia [49]. Some cases of supraventricular tachycardia may respond
to immediate treatment with a bolus of adenosine (12 mg IV) without the need of
cardioversion. Whenever possible, assess whether the patient can perceive the pain
associated with cardioversion, and if so provide appropriate sedation and analgesia.
In the stable patient, use the electrocardiogram (ECG) to determine the nature of the
arrhythmia. In the urgent settings in which ACLS algorithms are most often employed,
specific rhythm identification may not be possible. Nevertheless, by performing an orderly
review of the ECG, one can identify the appropriate ACLS management algorithm. Three
questions provide the basis for assessing the electrocardiogram in this setting:
Cardioversion of stable patients with irregular narrow complex tachycardias should NOT be
undertaken without considering the risk of embolic stroke. If the duration of atrial fibrillation
is known to be less than 48 to 72 hours, the risk of embolic stroke is low, and the clinician
may consider electrical or chemical cardioversion [54]. Chemical cardioversion may be done
with procainamide (50 mg/min IV, up to a dose of 18 to 20 mg/kg or until conversion),
ibutilide (0.01 mg/kg IV over 15 minutes), or amiodarone (5 mg/kg IV over 15 minutes).
(See "Rhythm control versus rate control in atrial fibrillation").